Due to the COVID-19 pandemic, many patients are unable to get a tissue biopsy for genomic testing at initial presentation of advanced cancer or upon its progression. Guardant Health has adopted a number of measures to enhance access for patients.
![]() |
MOBILE PHLEBOTOMY SERVICE In-home blood draws reduce the need for patients to come into your practice |
TO REQUEST MOBILE PHLEBOTOMY
![]() Fax received by Guardant Health |
![]() |
![]() Call to Guardant Health |
1-2 days to schedule the blood draw ![]() |
![]() Patient blood draw complete |
7 days ![]() |
![]() Guardant360 report released |
![]() |
EXPANDED PATIENT ASSISTANCE The Guardant Access Program now covers COVID-19-related financial hardships |
TO REQUEST MOBILE PHLEBOTOMY